LeapFrog Investments Strengthens Healthcare Team with Partner and Global Co-Lead, Dr Biju Mohandas
Nairobi, 24th February 2021: LeapFrog Investments, the Profit with Purpose investment firm, has bolstered its global healthcare team with the appointment of Dr Biju Mohandas. He will serve as Partner and Global Co-Lead for Healthcare, alongside partners Dr Felix Olale and Michael Fernandes, deepening LeapFrog’s distinctive investment expertise in this high-growth sector in emerging Asia and Africa.
LeapFrog’s healthcare companies include GoodLife, the largest pharmacy chain and healthcare provider in East Africa, and MedGenome, the leading South Asian genomic research and diagnostics company. Together, portfolio companies have reached millions of people with healthcare, protecting and enabling many vulnerable families and communities during the COVID-19 pandemic.
Dr Mohandas brings over two decades of investing, operating and leadership experience spanning 20 countries in Asia and Africa. He joins LeapFrog after nine years at the International Finance Corporation (IFC) where he led its Healthcare and Education investment team in Sub Saharan Africa and was the Global Sector Lead for Medical Devices. During this period, he played a pivotal role in deploying over half a billion dollars in investments across ten countries in Sub-Saharan Africa. In addition to profitable exits and significant top and bottom-line growth, the impact of these investments is felt annually by 4.2 million people who have access to healthcare, and a further 200,000 students with access to education.
Dr Mohandas was one of the early professionals to venture into the impact investment space in emerging markets as head of Acumen in East Africa and part of their founding team in India. He brings extensive experience of delivering returns and impact at scale. Having began his career as an officer in the Indian Army Medical Corps’ field ambulance in North Eastern India, Dr Mohandas experienced, first-hand, the challenges preventing delivery of healthcare, education, energy, housing, food and water to people in low-income communities. He has since dedicated his career to harnessing the power of private enterprises, capital and technology to achieve equitable access to these critical goods and services.
Dr Biju Mohandas, Partner and Global Co-Lead for Health Investments at LeapFrog Investments said: “I have long admired LeapFrog’s vision and dedication to measurable impact and industry-leading returns. I share Leapfrog’s vision of making essential healthcare accessible to millions of underserved consumers. Profit with Purpose represents a powerful synergy at a moment in history when it’s profoundly needed. Reaching one billion people with essential services by 2030 is an inspiring challenge, and I’m thrilled to be joining LeapFrog on that mission.”
Dr Felix Olale, Partner and Global Co-Lead for Healthcare at LeapFrog Investments said: “Biju is one of the strongest and most highly skilled investors I have had the privilege of working alongside. His acuity in investment is matched by an extremely admirable set of values and an unwavering commitment to impact. At a time of such global uncertainty, our healthcare team is dedicated to ensuring millions more people have access to safe and affordable health services and medicines. We’re delighted to welcome a stellar leader and emerging market champion to the team.”
NOTES TO EDITORS
About LeapFrog Investments
LeapFrog invests in exceptional businesses in Africa and emerging Asia, partnering with their leaders to achieve leaps of growth, profitability and impact. Founded in 2007, LeapFrog’s companies now reach 205 million people across 35 countries with healthcare or financial services. LeapFrog companies have also grown on average at more than 30 per cent a year from the time of investment. LeapFrog companies reach 164 million emerging consumers, living on less than $10 per day. LeapFrog’s companies now provide jobs or livelihoods to more than 128,000 people. Inspired by LeapFrog’s strategy of Profit with Purpose, global institutional investors have committed $US1.6 billion ($A2.2 billion) to the group’s private equity funds. LeapFrog was ranked by Fortune as one of the top five companies to change the world, alongside Apple and Novartis, becoming the first private investment firm ever listed.
Media contact for LeapFrog
0449 561 313